Dr. David Kang has named to one of the 'The Power List 50' by The Ophthalmologist.

"The Power List is gloriously subjective. Why?

Because it’s ophthalmologists who do the voting!

Thanks to the demographics of the developed world, the future

of eyecare looks like it will be one of limited resources and rising

patient burden. So who will lead ophthalmology over the next few

decades and shape its future? To find out, we asked you, our readers,

to vote for ophthalmology’s Top 50 rising stars… and here they are.

The Power Lists are all about celebrating effort and achievement."

The Ophthalmologist Editor |  Mark Hillen

F O U N D E R A N D    C L I N I C A L 

D I R E C T O R    A T    E Y E R E U M

O P H T H A L M I C    C L I N I C    A N D    C E O

O F E Y E R E U M    H E A L T H C A R E ,

T H E    R E P U B L I C    O F    K O R E A

-

"Davis Kang serves as outpatient Clinical Associate Professor at Ulsan University,

Asan Medical Center and as out-patient Assistant Clinical Professor at Severance

Hospital, Yonsei University School of Medicine in Seoul. His primary passion

is corneal wavefront-guided ablation for amelioration of aberrations for

keratoconus, cornea ectasia, and central islands. Kang has received three Best

Academic Achievement Awards from the Korean Ophthalmological Society,

including the Best Video Award. To date, he has rights to six patents. His first

patent, registered in 2008, involves using circumlinear capsulorhexis technology

during cataract surgery. Since then he has patented new methods of deepithelization

of the cornea prior to refractive surface ablation, removing

phakic IOLs, and removing lenticules during SMILE"

David Kang is attending ESCRS.
David Kang begins his medical treatment on October 12,2017